Mark Kowieski - Jan 28, 2025 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
Chief Financial Officer
Signature
/s/ Mark Kowieski
Stock symbol
EVOK
Transactions as of
Jan 28, 2025
Transactions value $
$0
Form type
4
Date filed
1/29/2025, 04:30 PM
Previous filing
Aug 8, 2024
Next filing
Mar 24, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVOK Stock Option (Right to Buy) Award $0 +13K $0.00 13K Jan 28, 2025 Common Stock 13K $4.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the total number of shares subject to the options shall vest on each monthly anniversary of August 7, 2024 (the "Vesting Commencment Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date.